IN42: Severe infections, sepsis, and systemic and cerebral inflammatory responses
IN42: Severe infections, sepsis, and systemic and cerebral inflammatory responses
The research group focuses its work on conducting clinical studies on the inflammatory response and biological markers in severe infections among critically ill patients.
Responsible researcher
- Mikel Celaya López:
- E-mail: mikel.celaya.sspa@juntadeandalucia.es
- ORCID: 0000-0002-9868-8880
Lines of research
- Line 1: Severe infections.
- Line 2: Pneumonia.
- Line 3: Bacteremia.
- Line 4: Sepsis.
- Line 5: Infection Prevention and Control in the ICU.
- Line 6: Diagnosis of serious infections.
- Line 7: Diagnostic biomarkers.
- Line 8: Response to antimicrobial therapy.
Keywords
- # Infections in Critically Ill Patients
- # Pneumonia
- # Bacteremia
- # Sepsis
- # Inflammatory Response
IN42: Severe infections, sepsis, and systemic and cerebral inflammatory responses
IN42: Severe infections, sepsis, and systemic and cerebral inflammatory responses
Responsible researcher
Mikel Celaya López:
Chief of the Intensive Care Medicine Department at the Hospital Universitario Puerta del Mar.
- E-mail: mikel.celaya.sspa@juntadeandalucia.es
- ORCID: 0000-0002-9868-8880
Members of the Team
- Principal Investigators:
- Mikel Celaya López (PI).
- Researchers:
- Antonio Gordillo Brenes.
- Mª Dolores Freire Aragón.
- Julia Mercedes Salas Martin.
- Ana Fernández Cuervo.
- Alejandra Patricia Garrino.
- Mario Raúl Contreras Virués.
- Alicia Cuadra Calahorra.
- Jaume Revuelto Rey.
- Fátima Rivas Gómez-Plana.
- Juan Francisco Brea Salvago.
IN42: Severe infections, sepsis, and systemic and cerebral inflammatory responses
IN42: Severe infections, sepsis, and systemic and cerebral inflammatory responses
Production
Find all of the group's publications ( Projects, Patents , and Publications) on the I+Salud Portal of the Andalusian Public Health System:
